Exchange: NASDAQ·Updated 07:30 PM EDT

ODTX Odyssey Therapeutics Inc

$28.76
$2.36
(8.94%)
Today
Closed $28.76
$0.00
(0.00%)
After Hours
EarningsNov 5
Mkt Cap$1.38B
Vol268,975.00

About ODTX

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company which develops medicines for autoimmune and inflammatory diseases. Its programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. The company was founded by Gary D. Glick, Melissa Merrick and David L. Pompliano in April 2021 and is headquartered in Boston, MA.
55

Bullish Sentiment

How do you feel about ODTX?

Advertisement|Remove ads.